Healthpeak Properties, Inc. (NYSE:DOC) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 0.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,153,450 shares of the real estate investment trust's stock after buying an additional 53,392 shares during the period. Charles Schwab Investment Management Inc. owned about 1.45% of Healthpeak Properties worth $205,810,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of DOC. Avior Wealth Management LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter worth $37,000. Groupama Asset Managment purchased a new position in Healthpeak Properties in the third quarter valued at about $37,000. Capital Performance Advisors LLP bought a new position in Healthpeak Properties in the third quarter worth about $42,000. Wiser Advisor Group LLC purchased a new stake in shares of Healthpeak Properties during the third quarter valued at about $42,000. Finally, Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at about $44,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

NYSE DOC traded up $0.21 during trading hours on Monday, reaching $20.72. The stock had a trading volume of 6,088,314 shares, compared to its average volume of 4,745,247. Healthpeak Properties, Inc. has a 52-week low of $16.66 and a 52-week high of $23.26. The stock has a fifty day moving average of $20.20 and a 200 day moving average of $21.29. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market cap of $14.49 billion, a P/E ratio of 59.19, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14.

Remove Ads

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a $0.305 dividend. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 5.89%. The ex-dividend date was Friday, February 14th. Healthpeak Properties's dividend payout ratio is 348.57%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on DOC. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Wells Fargo & Company reduced their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 10th. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, February 14th. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research note on Friday, February 28th. Finally, Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.